Lam Research Corporation

“Lam Research is a structurally exceptional business — dominant in etch and deposition, compounding via content-per-wafer expansion, financially fortress-grade, and earning 40–65% ROIC through the cycle. However, at 38.5x forward earnings, the stock has pre-loaded ~18% EPS CAGR through 2031 with zero allowance for WFE cyclicality, China export control escalation (~25% revenue exposure), or multiple normalization. The forward earnings yield of ~2.6% provides no compensation for these real, if manageable, risks. Permanent impairment of the business is unlikely (<10% probability); permanent impairment of capital at this entry point is a meaningful risk. The right action is to track patiently and build a position on cyclical or geopolitical-driven weakness — a 20–30% pullback to 28–32x forward would offer a genuinely attractive long-term entry into one of the world's best industrial franchises.”